Thus, aberrant placental p53 protein levels, with unchanged p53 mRNA expression as described by some studies for PE and IUGR cases, can be explained by regulation of p53 protein stability via Mdm2 or similar E3 ubiquitin ligases. The gene discussed is MDM2; the disease is fetal growth restriction.